Akerke Chayakova | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Akerke Chayakova
Astana Medical University, Kazakhstan

Akerke Chayakova
Affiliation Astana Medical University
Country Kazakhstan
Scopus ID 57226888892
Documents 4
Citations 6
h-index 2
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-8398-3684

Akerke Chayakova is affiliated with Astana Medical University and has contributed to research in medicine, emergency healthcare systems, public health analytics, and the application of digital technologies in healthcare. Her scholarly activities focus on emergency medical services, epidemiological assessment, geospatial health analysis, and healthcare decision-making processes. Through peer-reviewed publications and interdisciplinary investigations, her work contributes to evidence-based healthcare planning and the understanding of population-level health dynamics.[1]

Abstract

This article summarizes the research profile and academic contributions of Akerke Chayakova. Her research addresses emergency medical service performance, urban health environments, healthcare analytics, pandemic response assessment, and artificial intelligence applications in medicine. Through quantitative investigations and population-based studies, her work supports improvements in healthcare management, emergency response planning, and clinical decision support systems.[2]

Keywords

Emergency Medical Services, Public Health, Healthcare Analytics, Artificial Intelligence, Epidemiology, Geospatial Analysis, Medical Informatics, Health Systems Research.

Introduction

Contemporary healthcare research increasingly relies on data-driven approaches to understand disease patterns, optimize emergency response systems, and improve patient outcomes. Akerke Chayakova’s research aligns with these priorities by examining emergency healthcare utilization, environmental influences on health events, and the integration of innovative technologies into clinical practice.[3]

Research Profile

Her scholarly profile includes publications addressing cardiovascular emergencies, traumatic injury response systems, COVID-19 healthcare management, and the role of artificial intelligence in disease screening. These studies employ retrospective analyses, geospatial methodologies, and health data evaluation techniques to investigate factors affecting healthcare delivery and patient management.[4]

Research Contributions

  • Investigation of emergency medical service utilization and transport decision-making in ischemic heart disease.
  • Analysis of urban environmental factors influencing traumatic injury response patterns.
  • Assessment of emergency medical services during the COVID-19 pandemic.
  • Evaluation of artificial intelligence applications in periodontal disease diagnosis and screening.

Publications

  • Beyond Clinical Acuity: Cardiac Comorbidity and Complication Profiles and the Prehospital Hospitalization/Transport Decision in Ischemic Heart Disease (Healthcare, 2026).
  • Urban Environmental Determinants and Spatiotemporal Patterns of Emergency Medical Service Response to Traumatic Injuries (IJERPH, 2026).
  • Modern Approaches to the Integration of Artificial Intelligence into the Diagnosis and Screening of Periodontal Diseases (2026).
  • Geospatial and Temporal Analysis of Emergency Medical Services during the COVID-19 Pandemic (2025).

Research Impact

According to the available Scopus author profile, Akerke Chayakova has accumulated scholarly visibility through indexed publications, citations, and an emerging citation record. Her research contributes to public health evidence, healthcare planning, emergency response optimization, and digital health innovation. The integration of epidemiological analysis with practical healthcare challenges demonstrates the translational relevance of her work.[1]

Award Suitability

The Innovative Research Award recognizes researchers who demonstrate originality, scientific rigor, and meaningful contributions to their disciplines. Akerke Chayakova’s investigations into emergency medical systems, healthcare analytics, public health challenges, and artificial intelligence applications in medicine align with the objectives of innovation-focused academic recognition programs. Her interdisciplinary approach highlights the practical value of research in improving healthcare outcomes and system efficiency.[5]

Conclusion

Akerke Chayakova has established a developing research profile centered on medicine and health sciences. Her work contributes to the understanding of emergency healthcare systems, public health management, and emerging digital healthcare solutions. The combination of methodological analysis and healthcare application supports her recognition within contemporary medical research environments.

References

  1. Elsevier. (n.d.). Scopus author details: Akerke Chayakova, Author ID 57226888892. Scopus.
    https://www.scopus.com/pages/authors/57226888892
  2. Healthcare. (2026). Beyond Clinical Acuity: Cardiac Comorbidity and Complication Profiles.
    https://doi.org/10.3390/healthcare14152308
  3. International Journal of Environmental Research and Public Health. (2026). Urban Environmental Determinants and Spatiotemporal Patterns.
    https://doi.org/10.3390/ijerph23040434
  4. Journal of Health Development. (2026). Artificial Intelligence in Diagnosis and Screening of Periodontal Diseases.
    https://doi.org/10.32921/2663-1776-2026-61-1-jhd059
  5. Portuguese Journal of Public Health. (2025). Geospatial and Temporal Analysis of Emergency Medical Services during the COVID-19 Pandemic.
    https://doi.org/10.1159/000549009

Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Published on by Forensic Scientist Awards

Assoc. Prof. Dr. Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Izmir Katip Çelebi University Atatürk Training and Research Hospital | Turkey

Dr. Tuncay Kırış, an Associate Professor at İzmir Kâtip Çelebi University, Izmir, Turkey, is a distinguished cardiology researcher recognized for his extensive contributions to cardiovascular medicine, particularly in the fields of cardiovascular risk prediction, interventional cardiology, acute coronary syndromes, and cardiac biomarkers. His research has provided valuable insights into myocardial infarction, pulmonary embolism, renal complications following cardiac interventions, and the prognostic implications of biochemical and hematological markers in predicting patient outcomes. Dr. Tuncay Kırış has authored 83 peer-reviewed publications in prestigious international journals indexed in SCI and SCI-Expanded, including Angiology, BMC Cardiovascular Disorders, The Anatolian Journal of Cardiology, Clinical and Experimental Hypertension, Herz, and Acta Radiologica. His works have received 591 citations from 544 documents, with an h-index of 15, according to Scopus (Author ID: 55321350600), reflecting his strong academic impact. His studies emphasize innovative predictive and prognostic modeling approaches, such as exploring the fibrinogen-to-albumin ratio, red cell distribution width, and lymphocyte-to-monocyte ratio as novel indicators of adverse cardiovascular events and renal complications. Beyond his research, he has supervised postgraduate theses on cardiovascular risk assessment, contributed to collaborative projects in clinical and translational cardiology, and serves as Editor of the Ege Klinikleri Tıp Dergisi. As an active reviewer for several international cardiology journals, Dr. Tuncay Kırış continues to advance evidence-based cardiology through data-driven research, bridging clinical practice with innovation to improve patient outcomes and global cardiovascular health.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  • Yildirim, S. E., Yildirim, T., Kırış, T., & Avci, E. (2025, October). Prognostic value of the NAPLES score and serum uric acid in chronic coronary syndrome: Evidence from time-dependent ROC and time-varying hazard ratio analyses. Journal of Clinical Medicine, 14(20), 7416. https://doi.org/10.3390/jcm14207416

  • Tiryaki, M. M., Yılmaz, C., Ince, H. S., Karaca, B., Kayaalti Esin, F., & Kırış, T. (2025, September). Neutrophil percentage-to-albumin ratio as a predictor of in-hospital mortality in infective endocarditis. Biomarkers in Medicine, 19(17), 1–8. https://doi.org/10.1080/17520363.2025.2562554

  • Akkan, G., Kırış, T., Esin, F., & Karaca, M. (2025, May). Evaluation of mortality and hospitalization due to decompensated heart failure and appropriate shocks in reduced ejection fraction in patients with an implantable cardioverter–defibrillator according to a novel tissue Doppler echocardiographic method. Journal of Clinical Medicine, 14(9), 3226. https://doi.org/10.3390/jcm14093226

  • Esin, F., Bozkurt, H., Palac, B., Akar, B., Kırış, T., Özdemir, E., & Karaca, M. (2025, February). The impact of pleural effusion on long-term mortality in patients undergoing transcatheter aortic valve implantation. Journal of Clinical Medicine, 14(5), 1596. https://doi.org/10.3390/jcm14051596

  • Usta, A., Sancakli Usta, C., Lafci, D., Kırış, T., & Avci, E. (2024, December). Contrast induced nephropathy in women with infertility undergoing hysterosalpingography. Reproductive Biology and Endocrinology, 22(1). https://doi.org/10.1186/s12958-024-01334-3

Oguz Ozcelik | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Prof. Dr. Oguz Ozcelik | Medicine and Health Sciences | Best Researcher Award

Kastamonu University | Turkey

Dr. Oğuz Özçelik (MD, PhD) is a distinguished Professor at Kastamonu University, Turkey, widely recognized for his pioneering work in exercise physiology, metabolism, and oxidative stress. His academic foundation in medicine and physiology has driven decades of impactful research exploring the complex relationships between aerobic fitness, respiratory regulation, and metabolic health. Through rigorous experimental design and translational insights, he has advanced understanding of how exercise modulates physiological and biochemical responses in both healthy and clinical populations. Dr. Oğuz Özçelik’s scientific contributions span more than forty peer-reviewed publications in international journals, reflecting depth, innovation, and clinical relevance. His notable works include studies on the relationship between aerobic fitness levels and isocapnic buffering periods during incremental exercise tests (Cellular and Molecular Biology, 2017, cited by 132), the effects of body mass index on maximal work production and aerobic capacity (Physiological Research, 2004, cited by 84), and the role of nesfatin-1 in glucose tolerance and depressive disorders (Physiological Research, 2016; Psychiatry Investigation, 2018). With an h-index of 13 and more than 474 citations, his scholarly influence demonstrates sustained research excellence. Dr. Oğuz Özçelik’s current investigations focus on the hormonal and metabolic adaptations to exercise and their relevance to neuroendocrine and cardiometabolic health. His leadership, academic rigor, and enduring contributions to human performance and biomedical science exemplify the highest standards of professional achievement and research integrity within the global scientific community.

Profile: Scopus | Google Scholar | ORCID

Featured Publications

  1. Algul, S., Ozcelik, O., & Yilmaz, B. (2017). Evaluation of relationship between aerobic fitness level and range of isocapnic buffering periods during incremental exercise test. Cellular and Molecular Biology, 63(3), 78–82.

  2. Ozcelik, O., Aslan, M., Ayar, A., & Kelestimur, H. (2004). Effects of body mass index on maximal work production capacity and aerobic fitness during incremental exercise. Physiological Research, 53(2), 165–170.

  3. Algul, S., Ozkan, Y., & Ozcelik, O. (2016). Serum nesfatin-1 levels in patients with different glucose tolerance levels. Physiological Research, 65(6), 979–985.

  4. Ozcelik, O., Ward, S. A., & Whipp, B. J. (1999). Effect of altered body CO₂ stores on pulmonary gas exchange dynamics during incremental exercise in humans. Experimental Physiology, 84(5), 999–1011.

  5. Algul, S., & Ozcelik, O. (2018). Evaluating the levels of nesfatin-1 and ghrelin hormones in patients with moderate and severe major depressive disorders. Psychiatry Investigation, 15(2), 214–218.

Hanchen Zhou | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Mr. Hanchen Zhou | Medicine and Health Sciences | Best Researcher Award

Beijing Stomatological Hospital Affiliated to Capital Medical University | China

Hanchen Zhou, a graduate student at Beijing Stomatological Hospital, Capital Medical University, is an emerging researcher specializing in Oral and Maxillofacial-Head and Neck Oncology, with a primary focus on oral squamous cell carcinoma. He has already distinguished himself by publishing four SCI-indexed research papers that contribute valuable insights into the molecular mechanisms, clinical behavior, and potential treatment strategies for this aggressive malignancy. These publications, cited internationally, reflect his growing influence in oncology research and his ability to translate clinical challenges into innovative scientific solutions. Zhou is actively engaged in funded research projects, including the Innovation Foundation and the Clinical Research Incubation Project of Beijing Stomatological Hospital, demonstrating his capacity to design and execute impactful investigations. A member of the Chinese Stomatological Association, he actively participates in academic collaboration and professional development, strengthening his role within the wider scientific community. Despite being in the early stages of his career, Zhou has already showcased a strong commitment to advancing cancer research, particularly in bridging experimental findings with clinical applications. His work not only enhances the understanding of oral squamous cell carcinoma but also paves the way for improved diagnostic and therapeutic approaches. By integrating scientific rigor with a clear vision for innovation, he exemplifies the qualities of a promising researcher poised for long-term impact.

Profile: Scopus | ResearchGate

Featured Publications

  • Yu, H., Li, B., Huang, Y., & Zhang, X. (2025). Prognosis of second primary oral squamous cell carcinoma after hematologic malignancy: A retrospective cohort analysis. Frontiers in Oncology, 15, Article 1667226. https://doi.org/10.3389/fonc.2025.1667226

  • Zhou, H., Luo, C., Xu, Q., & Wang, C. (2025). Machine learning approach to predict surgical site infection in head and neck squamous cell carcinoma patients after free flap reconstruction. Journal of Cranio-Maxillofacial Surgery. Advance online publication. https://doi.org/10.1016/j.jcms.2025.09.010

  • Cheng, A., Wei, K., Xu, Q., & Wang, C. (2025). The comparison of the prognostic value of different inflammation-related indicators in patients with oral squamous cell carcinoma. Frontiers in Genetics, 16, Article 1652603. https://doi.org/10.3389/fgene.2025.1652603

  • Li, B., Zhao, Z., Huang, Y., & Zhou, H. (2025). The application of adjuvant radiotherapy in pN1 OSCC patients without adverse pathologic features. Oral Diseases, 31(1), e15336. https://doi.org/10.1111/odi.15336

Zhechun Wu | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Mr. Zhechun Wu | Medicine and Health Sciences | Best Researcher Award

Chaoyang Hospital | China

Mr. Zhechun Wu is a resident physician in the Department of Urology at Beijing Chaoyang Hospital, Capital Medical University, Beijing, China, who has established himself as an emerging clinician–scientist combining medical training with impactful research. He earned his Bachelor of Science degree from Capital Medical University and is currently advancing his clinical expertise through residency while contributing to translational oncology research. His work is focused on prostate cancer, with particular emphasis on identifying therapeutic targets that regulate tumor immunity, a critical area for developing next-generation treatment strategies. Mr. Zhechun Wu has published in reputable international journals, including a recent article in Investigational New Drugs that explored drug targets modulating tumor immune response, a study that has already been cited in related scholarly work, reflecting its scientific significance. His projects are supported by competitive funding from the National Natural Science Foundation of China  and the Beijing Natural Science Foundation, highlighting his ability to secure prestigious grants and deliver research with clinical and academic value. Alongside research, his clinical practice in urology, oncology, and kidney transplantation strengthens his understanding of patient-centered challenges, allowing him to align laboratory findings with real-world medical needs. This dual role as physician and researcher equips him to contribute to both advancing cancer therapeutics and improving clinical outcomes, establishing a foundation for future leadership in medical innovation and academic research.

Profile: ORCID

Featured Publications

Zhang, Y., Qiu, X., Wu, Z., Li, Y., Shen, X., Wu, J., Cao, P., Sun, Z., & Wang, W. (2025). Comprehensive analysis of the association between volatile organic compound pollutants and chronic kidney disease in hypertensive populations: Insights from multi-omics approaches and identification of potential therapeutic targets. Environmental Research, 121966.

Wu, Z., Li, S., Li, Y., Wang, Z., & Wang, W. (2025). Identifying potential therapeutic targets for prostate cancer with mediating role in tumor immunity. Discover Oncology, 16, 98.

Wu, Z. (2025). Higher sexual frequency correlated with lowered PSA complex levels in U.S. men over 40 and without prostate conditions: A nationwide cross-sectional study. The Journal of Sexual Medicine.

Rui Guo | Medicine | Excellence in Innovation Award

Published on by Forensic Scientist Awards

Dr. Rui Guo | Medicine | Excellence in Innovation Award

Children’s Hospital Affiliated to Shandong University | China

Dr. Rui Guo is a thoracic and tumor surgeon specializing in pediatric minimally invasive surgery. Affiliated with the Children’s Hospital of Shandong University and Jinan Children’s Hospital, his work focuses on innovative thoracoscopic techniques for congenital lung malformations.

Professional profile👤

Scopus

Strengths for the Awards✨

  1. Innovative Surgical Technique

    • Introduces a novel “Single Surgeon + Single Site” thoracoscopic approach for pediatric extralobar pulmonary sequestration (ELS), reducing incisions, operative time, and resource use compared to multi-portal VATS (M-VATS).

    • Addresses limitations of existing techniques (e.g., U-VATS) by enabling artificial pneumothorax and minimizing instrument interference.

  2. Clinical Impact

    • Demonstrates superior outcomes: Shorter operative time (41.8 vs. 53.7 min), reduced blood loss (2.7 vs. 4.1 mL), and shorter hospital stays (3.7 vs. 6.5 days) compared to M-VATS.

    • Cost-effective: Lower expenses ($4,228 vs. $4,978) due to fewer consumables and no need for surgical assistants.

  3. Technical Feasibility

    • Successful implementation in 18 patients with no conversions to open surgery or major complications (e.g., bronchopleural fistulas).

    • Adaptability to complex cases (e.g., intra-diaphragmatic ELS with diaphragmatic repair).

  4. Alignment with Modern Surgical Trends

    • Promotes minimally invasive and enhanced recovery protocols, aligning with global shifts toward less traumatic pediatric surgeries.

  5. Rigor and Transparency

    • Retrospective design but includes clear statistical analysis and comparative data.

    • Ethical approval and informed consent were obtained.

Education 🎓

  • Medical Degree: Likely from a Chinese medical institution (specific details not provided in the publication).

  • Training: Specialization in pediatric thoracic surgery, with expertise in video-assisted thoracoscopic surgery (VATS).

Experience 💼

  • Current Roles:

    • Thoracic Surgeon at Jinan Children’s Hospital.

    • Researcher in minimally invasive pediatric surgical techniques.

  • Key Contributions: Pioneered “Single Surgeon” and “Single Site” thoracoscopic approaches for pulmonary sequestration.

Research Interest On Medicine🔍

  • Minimally invasive surgery (VATS) for congenital lung lesions.

  • Cost-effective and resource-efficient surgical techniques.

  • Postoperative recovery optimization in pediatric patients.

Publication 📄

Guo et al. (2025) “Single surgeon and single site total thoracoscopic surgery for paediatric extralobar pulmonary sequestration.” BMC Pediatrics, 25:446.
🔗 Read Here | Cited by: [X] articles (check citation count on PubMed/Google Scholar).

Conclusion ✨

Dr. Rui Guo, innovative thoracoscopic techniques demonstrate improved surgical outcomes, reduced costs, and faster recovery for pediatric ELS patients. His work supports broader adoption of minimally invasive approaches in pediatric thoracic surgery.